{
    "2021-09-26": [
        [
            {
                "time": "",
                "original_text": "医药生物行业：海外新冠治疗药物有望Q4陆续获批 重点推荐相关CDMO标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠治疗药物",
                        "Q4获批",
                        "CDMO"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业资金流入榜：6股净流入资金超亿元",
                "features": {
                    "keywords": [
                        "医药生物",
                        "资金流入",
                        "6股",
                        "净流入资金"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}